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Cancer cells reprogram their metabolism, altering
both uptake and utilization of extracellular nutrients.
We individually depleted amino acid nutrients from
isogenic cells expressing commonly activated onco-
genes to identify correspondences between nutrient
supply and viability. In HME (human mammary
epithelial) cells, deprivation of cystine led to
increased cell death in cells expressing an activated
epidermal growth factor receptor (EGFR) mutant.
Cell death occurred via synchronous ferroptosis,
with generation of reactive oxygen species (ROS).
Hydrogen peroxide promoted cell death, as both
catalase and inhibition of NADPH oxidase 4 (NOX4)
blocked ferroptosis. Blockade of EGFR or mitogen-
activated protein kinase (MAPK) signaling similarly
protected cells from ferroptosis, whereas treatment
of xenografts derived from EGFR mutant non-
small-cell lung cancer (NSCLC) with a cystine-
depleting enzyme inhibited tumor growth in mice.
Collectively, our results identify a potentially exploit-
able sensitization of some EGFR/MAPK-driven tu-
mors to ferroptosis following cystine depletion.INTRODUCTION
Synthetic lethal screens have led to the identification of specific
cancer cell vulnerabilities (Barbie et al., 2009; Possik et al., 2014;
Scholl et al., 2009). One such vulnerability has previously beenCell R
This is an open access article under the CC BY-Nexploited therapeutically in acute lymphoblastic leukemia
(ALL), where leukemic cells lacking asparagine synthase are
known to require the amino acid asparagine and apoptose
following administration of asparaginase (Holleman et al.,
2003; Tallal et al., 1970). Overall amino acid abundance itself
may be higher in cancerous tissue, suggesting an increased
need for amino acids in some tumors (Hirayama et al., 2009;
Kami et al., 2013). In pancreatic ductal adenocarcinoma
(PDAC), KRAS is thought to induce a genetic program that favors
metabolism of glutamine, rendering these cells particularly sen-
sitive to glutamine withdrawal (Son et al., 2013). Some tumor cell
lines (Scott et al., 2000) and primary tumors (Gonzalez and Byus,
1991) require exogenous arginine, indicating some selectivity in
amino acid requirements. Here, we have explored the extracel-
lular amino acid nutrient requirements of cells gene edited to
introduce common oncogenic mutations. We identify a selective
sensitivity to synchronous cell death by ferroptosis following
deprivation of the amino acid nutrient cystine. Sensitization
was found to be related to elevatedmitogen-activated protein ki-
nase (MAPK) signaling, with synchronous cell death involving
hydrogen peroxide generation and release. Finally, we show
that enzymatic cystine deprivation in vivo results in an inhibition
of tumor growth in an EGFR mutant NSCLC xenograft model,
suggesting that, by promoting ferroptosis, cystine depletion pro-
vides therapeutic benefit in some tumors.RESULTS
EGFR Mutant HME Cells Undergo Cell Death when
Deprived of the Amino Acid Nutrient Cystine
Human mammary epithelial (HME) cells were gene edited to
introduce common oncogenic driver mutations (epidermaleports 18, 2547–2556, March 14, 2017 ª 2017 The Authors. 2547
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Deprivation of Cystine Induces Selective Cell Death by Ferroptosis in EGFR Mutant HME Cells
(A) Cell viability screen of HME cell lines deprived of individual amino acids for 72 hr. Histograms represent the average viability ± SD of three biological replicates
relative to complete media assigned a value of 1 (+AA).
(B) Phase contrast micrographs of wild-type (WT) and EGFR (delE746-A750) HME cells deprived of cystine for 24 hr. Arrowheads indicate membrane
extrusions.
(C) Time-lapse phase contrast (left) and Sytox Green (right) micrographs of live EGFR (delE746-A750) cells deprived of cystine for various times up to 24 hr.
(legend continued on next page)
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growth factor receptor [EGFR] [delE746-A750], KRAS [G13D],
BRAF [V600E], and PIK3CA [H1047R]) in an otherwise diploid ge-
netic background (Di Nicolantonio et al., 2008). Following culture
in media deficient in specific amino acids, we measured cell
viability. All lines deprived of L-cystine (cystine) exhibited some
loss of viability ranging from 40% to >80%. However, EGFR
and BRAF mutant HME cells were especially sensitive, with
viability inhibited by >80% (Figure 1A). Cystine deprivation
induced a widespread loss of viability in EGFR mutant, but not
wild-type HME, cells, with the majority of cells exhibiting a
swollen or burst morphology (Figure 1B).
Next, we monitored EGFR mutant HME cells deprived of
cystine by video time-lapse microscopy and observed rapid
and synchronous cell swelling/bursting (Figure 1C; Movie S1).
Sytox Green, a cell-impermeant nuclear stain, synchronously
entered cells after cystine depletion (Figure 1C), indicating loss
of plasma membrane integrity at <2 mM cystine (Figure 1D).
Death was reversible upon re-supplementation of cystine for
up to 10 hr but declined progressively thereafter and was not
prevented by addition of D-cystine (Figure S1A).
Cell Death in Cystine-Deprived EGFR Mutant HME Cells
Exhibits Hallmarks of Ferroptosis
This type of death resembled ferroptosis, an iron-dependent
non-apoptotic cell death (Dixon et al., 2012). Because lipid
reactive oxygen species (ROS) accumulation characterizes fer-
roptosis (Dixon et al., 2012), we measured ROS. Fluorescence-
activated cell sorting (FACS) analysis indicated increased ROS
accumulation in EGFRmutant HME cells following cystine depri-
vation (Figure 1E). EGFR mutant HME cells treated with known
ferroptosis inhibitors inhibited lipid ROS generation (Figure 1F)
and protected EGFR mutant (and BRAF mutant; Figure S1B)
cells from cell death (Figure 1G), as did treatment with two other
antioxidants (Figure 1H). Finally, erastin, an inhibitor of the sys-
tem xc-cystine/glutamate antiporter (Dixon et al., 2012), also
induced selective loss of viability in EGFR mutant cells (Fig-
ure 1H). Collectively, these data indicate that cell death in
EGFR mutant cells occurs by ferroptosis.
MAPK Signaling Sensitizes EGFR Mutant Cells to Cell
Death following Cystine Deprivation
EGFR activation results in activation of downstream signaling
cascades (Pines et al., 2010). Ferroptosis had previously been
shown to require MAPK signaling (Yagoda et al., 2007; Dixon
et al., 2012). Treatment of EGFR mutant cells for >24 hr with(D) Cell viability following titration of cystine in WT and EGFR (delE746-A750) H
various concentrations of cystine ± EGF, relative to complete media (150 mM cy
(E) ROS in WT HME and EGFR (delE746-A750). (Upper panels) Total ROS measu
C11 BODIPY 581/591 (C11-BODIPY) is shown. Dark traces, cells cultured in norm
(F) Lipid ROS in WT and EGFR (delE746-A750) HME cells. Dark traces, cells cultu
ferrostatin (Fer-1; 2 mM) for 12 hr; light traces, cells cultured in media lacking cys
(G) Cell viability of EGFR (delE746-A750) HME cells. Histogram is average viabilit
arbitrary value of 1) or media lacking cystine for 24 hr (right four bars) in the pres
(H) Cell viability (bottom histogram) and phase-contrast microscopy (upper pane
three biological replicates cultured in normal media (assigned an arbitrary value
scavengers idebenone and a-tocopherol.
(I) Cell viability of WT (gray bars) and EGFR (delE746-A750; black bars) HME cells.
or media lacking cystine for 24 hr in the presence or absence of erastin and Fer-EGFR or MAPK (MEK and ERK1/2) inhibitors inhibited EGFR
and MAPK signaling (Figures 2A and S2A), restored normal
adherens junction formation and gap junctional intercellular
communication (GJIC) (Figures 2B and 2C), and rescued cell
viability following cystine withdrawal (Figures 2D and S2B). Like-
wise, EGFR and MAPK inhibition in EGFR mutant cells inhibited
ROS generation (Figures 2E, S2C, and S2D).
Cystine Promotes Viability in EGFR Mutant HME Cells
via a Glutathione-Independent Mechanism
HME cells might resist ferroptosis by maintaining intracellular
levels either of cystine or glutathione, the major cystine-derived
antioxidant. To address the former possibility, we deprived cells
of cystine and measured activation of GCN2, a sensor of amino
acid depletion (Hinnebusch, 2005). However, in both wild-type
and EGFR mutant HME cells, GCN2 was equivalently activated
following cystine deprivation (Figure 3A). Basal cystine levels
were also equivalent and declined similarly in wild-type and
EGFR mutant cells following extracellular cystine depletion (Fig-
ure S3A). Recent data have suggested a role for glutaminolysis in
promoting ferroptosis (Gao et al., 2015). However, both wild-
type and EGFRmutant HME cells contained similar steady-state
intracellular levels of glutamine that were largely unaltered by
deprivation of cystine (Figure S3A). Similarly, total levels of gluta-
thione declined equivalently in wild-type and EGFR mutant
HME cells following cystine deprivation (Figure 3B). However,
Iressa-treated EGFR mutant cells accumulated more oxidized
glutathione (GSSG) in comparison to untreated EGFR mutant
HME cells following deprivation of cystine, suggesting that
EGFR inhibition increased ROS detoxification (Figure 3C). Sur-
prisingly, an inhibitor of glutathione synthesis (buthionine sulfox-
imine [BSO]), although also depleting glutathione levels, did not
induce cell death (Figure 3D) nor increase ROS in EGFR mutant
HME cells, unlike deprivation of cystine (Figure S3B). We there-
fore asked whether short-term deprivation of cystine, or inhibi-
tion of cystine import, acted synergistically with glutathione
depletion to induce cell death. Indeed, short-term deprivation
of cystine or treatment with inhibitors of the system xc-antiporter
induced significantly increased cell death when combined with
glutathione depletion (Figure 3E). Treatment with auranofin, an
inhibitor of the thioredoxin reductase/thioredoxin (TRX) system
(Gromer et al., 1998) implicated in reduction of cystine to
cysteine (Mandal et al., 2010; Pader et al., 2014), also synergized
with glutathione depletion to promote loss of viability and lipid
ROS induction (Figures S3B and S3C). Thus, EGFR mutant cellsME cells. Histogram represents the average viability ± SD of cells cultured in
stine; assigned an arbitrary value of 1).
red using CMDCFDA (DCF) is shown; (lower panels) lipid ROS measured using
al media for 12 hr; light traces, cells cultured in media lacking cystine for 12 hr.
red in media lacking cystine in the presence of deferoxamine (DFO; 100 mM) or
tine for 12 hr.
y ± SD cells cultured in normal media (left four bars, untreated [] assigned an
ence or absence of DFO, Fer-1, and z-VAD-fMK.
ls) of EGFR (delE746-A750) HME cells. Histogram is average viability ± SD of
of 1) or media lacking cystine for 24 hr in the presence or absence of ROS
Histogram represents the average viability ± SD cells cultured in normal media
1.
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B Figure 2. Active MAPK Signaling Promotes
Sensitivity to Cystine Deprivation
(A) Immunoblots of EGFR (delE746-A750) HME
cell lysates probed to detect phosphorylated
EGFR, ERK, and AKT from cells cultured in normal
media (normal) or media lacking cystine for 12 hr
(Cys) in the presence or absence of inhibitors
added for a total of 30 hr.
(B) Confocal micrographs of adherens junctions
stained with b-catenin antibody of WT or EGFR
(delE746-A750) HME cells treated with vehicle
(EGFR) or following treatment with inhibitors
for 30 hr. Arrows indicate linear staining for
b-catenin at intercellular junctions; arrowheads
indicate presence of discontinuous adherens
junctions.
(C) (Left panels) Fluorescence micrographs of
GJIC measured by lucifer yellow infiltration in
WT, EGFR (delE746-A750), Iressa-treated EGFR
(delE746-A750; EGFR/Iressa), and selumetinib-
treated EGFR (delE746-A750; EGFR/MEKi) in the
presence or absence of carbenoxolone (CBX).
(Right histogram) Quantification of GJIC is shown.
Each condition was analyzed in six random 203
fields in three biological replicates with the values
shown representing the mean and SEM and ex-
pressed relative to GJIC in WT HME cells as-
signed an arbitrary value of 1. Light bars represent
GJIC in the presence of CBX.
(D) Cell viability (left histogram) and phase-
contrast micrographs (right panels) of EGFR
(delE746-A750) HME cells treated with inhibitors.
Histogram is viability ± SD of cells cultured in
normal media (dark bars) or media lacking cystine
for 16 hr (light bars) in the presence or absence of
inhibitors. Results were expressed for each con-
dition separately, with viability in normal media
assigned the arbitrary value of 1.
(E) FACS analyses of lipid ROS in EGFR (delE746-
A750) cells following treatment with inhibitors.
Dark traces, cells cultured in normal media; light
traces, cells cultured in media lacking cystine
for 12 hr.oxidize less glutathione during cystine deprivation, contributing
to ROS accumulation, whereas intracellular cysteine appears
to play an additional role, aside from glutathione synthesis, in
counteracting ROS and ferroptosis.
GPX4 Is Downregulated in EGFR Mutant HME Cells via
MAPK Signaling and Modulates Sensitivity to Cell Death
upon Cystine Deprivation
Glutathione peroxidases (GPXs) are good candidates for medi-
ating sensitivity to ferroptosis. GPX4 has previously been impli-
cated in ferroptosis (Friedmann Angeli et al., 2014; Yang et al.,
2014), whereas GPX4 is induced following treatment with a
BRAF inhibitor (Parmenter et al., 2014). By immunoblotting,
GPX4, but not GPX1, expression was upregulated following
either EGFR or MAPK (MEK and ERK; Figure S3D) inhibition,
whereas GPX2 was not expressed in these cells (Figure 3E)
and GPX3 is a secreted GPX expressed in the kidney (Maser2550 Cell Reports 18, 2547–2556, March 14, 2017et al., 1994). Suppression of GPX4 strongly promoted cell
death in both wild-type (Figure 3G) and Iressa-treated EGFR
mutant cells (Figure 3H). Lipid ROS similarly increased after
suppression of GPX4 (Figure 3I). Thus, downregulation of
GPX4 in EGFR mutant HME cells conferred increased sensitivity
to ferroptosis following cystine deprivation. To determine
whether loss of viability was related to low levels of GPX4, we
expressed Flag-GPX4 in EGFR mutant cells. Indeed, ectopic
expression of GPX4 significantly increased viability following
deprivation of cystine (Figure 3J). Thus, downregulation of
GPX4 plays a key role in sensitizing EGFR mutant HME cells to
ferroptosis.
Synchronous Cell Death in EGFR Mutant HME Cells
Involves Generation and Release of Hydrogen Peroxide
Hydrogen peroxide is implicated in synchronous ferroptosis
in kidney tubule epithelia (Linkermann et al., 2014). Media
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Figure 3. Involvement of Intracellular Cysteine, GPX4, and Hydrogen Peroxide in Sensitivity to Ferroptosis
(A) Immunoblots of cell lysates probed with an antibody to active GCN2 (T899-P). Cells were cultured in normal media for 24 hr (normal) or media lacking cystine
for various times.
(B) Histogram of total glutathione levels in WT and EGFR (delE746-A750) cells cultured in normal media for 12 hr (N) or media lacking cystine for 8 or 12 hr. As a
positive control, BSO was added to cells for 12 hr to deplete the glutathione pool by inhibiting glutathione synthesis.
(C) Timecourseof glutathione oxidation (GSSG/total) in EGFR (delE746-A750) treatedwith vehicle (EGFR/DMSO) or Iressa for 30hr (EGFR/Iressa). Cellswere cultured
in media lacking cystine for 4 or 8 hr. Chart displays the average ratio of oxidized glutathione (GSSG) to total glutathione (GSH+GSSG) of three biological replicates.
(legend continued on next page)
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containing soluble catalase similarly rescued viability of EGFR
mutant HME cells (Figure 3K). Hydrogen peroxide is produced
by NADPH oxidase 4 (NOX4) (Takac et al., 2011). A NOX4 inhib-
itor (GKT136901; Laleu et al., 2010) also rescued viability, to the
same degree as addition of catalase (Figure 3K), and inhibited
lipid ROS generation (Figure 3L). NOX4 expression was also
increased in EGFR mutant HME cells and downregulated by
both EGFR and MAPK inhibition (Figure S3E). Finally, increased
accumulation of hydrogen peroxide was detected following
deprivation of cystine in EGFR mutant cells (Dickinson et al.,
2010; Figure 3M). Thus, hydrogen peroxide contributes to loss
of viability of EGFR mutant HME cells deprived of cystine.
NSCLC Tumor Cell Lines Exhibit a Targetable Sensitivity
to Ferroptosis
Mutations in the EGF receptor are found in non-small-cell lung
cancers (NSCLCs) (Pao et al., 2004) that are sensitive to tyrosine
kinase inhibitors (TKIs) (Paez et al., 2004). We removed cystine
from NSCLC cell lines and measured viability and MAPK activa-
tion. Of nine NSCLC cell lines tested, three with the highest
MAPK signaling (Figure S4A) demonstrated significant loss of
viability following withdrawal of cystine (Figures 4A and S4B).
In H3255 cells (EGFR L858R mutant), sensitivity was reversed
by either EGFR or MAPK inhibition, whereas in Calu-6 cells
(KRAS Q61K mutant), sensitivity was reversed by MAPK, but
not EGFR, inhibition (Figure S4C). Thus, in NSCLC cell lines,
the magnitude of MAPK activation is an important determinant
in sensitization to ferroptosis, rather than the nature of the
specific oncogenic driver that promotes MAPK signaling. In
NCI-NH1650 cells (EGFR delE746-A750), viability was restored
by addition of either a-tocopherol, the ferroptosis inhibitor
Fer-1 (Figure 4B), or Iressa (data not shown) following cystine
depletion, indicating that ferroptosis and EGFR signaling were
responsible for loss of viability. Surprisingly, however, MEK inhi-(D) Cell viability of WT (light bars) or EGFR (delE746-A750; dark bars) HME cells
normal media (N), normal media containing 200 mM BSO (N/BSO), or media lack
(E) Cell viability of EGFR (delE746-A750) pre-treated for 18 hr with DMSO vehicl
containing erastin (N/Erastin), or S4PG (N/S4PG) for 12 hr or following removal of
cultured in normal media (assigned a value of 1).
(F) Immunoblots of WT and EGFR (delE746-A750) cell lysates probed for GPX4, G
ERKwas calculated using ImageJ from scanned autoradiographs of three biologic
(G) (Left panels) Immunoblots of WT HME lysates probed for GPX4, GPX1, and E
(light bars) or media lacking cystine (dark bars) for 24 hr. Histogram represents the
for each condition separately, with viability in normal media assigned a value of
(H) (Left panels) Phase-contrast micrographs of EGFR (delE746-A750) HME cells f
(siGPX4) and treated with Iressa for 30 hr followed by culture in normal media
knockdown ofGPX1–4 in Iressa-treated EGFR (delE746-A750) cells. Viability of ce
determined. Results were expressed for each condition separately, with viability
(I) FACS analyses of lipid ROS inWT HME cells following knockdown of GPX1 and
media lacking cystine for 12 hr.
(J) Histogram is shown representing the average viability ± SD following overe
Viability of WT HME cells or vector- or GPX4-transfected EGFR (delE746-A750) ce
16 hr is shown. Results were expressed for each condition separately, with viab
(K) (Top panels) Phase-contrast micrographs of EGFR (delE746-A750) HME cells
GKT136901. (Bottom) Histogram representing the average viability ± SD of EGFR
a value of 1) or media lacking cystine alone (Cys) or with BSA, catalase, supero
(L) FACS analyses of lipid ROS in EGFR (delE746-A750) HME cells following treat
lacking cystine; light traces, cells cultured in normal media.
(M) Live images of hydrogen peroxide detected with PO1. (Left) Phase-contrast im
incubated with PO1 (right panels) are shown.
2552 Cell Reports 18, 2547–2556, March 14, 2017bition in these cells did not rescue viability following cystine
depletion (data not shown). Thus, MAPK activation may not
invariably promote sensitivity to ferroptosis, and other unknown
EGFR-dependent signaling pathway(s) can substitute.
Survival after treatment with TKIs in NSCLC is typically less
than 1 year, with patients developing secondary EGFR muta-
tions (Stewart et al., 2015). We therefore sought to determine
whether EGFR mutant NSCLC cells might be responsive to
low levels of cystine, potentially offering additional therapeutic
options utilizing a novel cystine/cysteine-degrading enzyme
(cyst(e)inase; AECase) engineered from cystathionine-g-lyase
(Cramer et al., 2017). Addition of AECase reduced viability in
both HME delE746-A750 EGFR or NCI-NH1650 cells (Figures
4C and 4D) and induced widespread uptake of Sytox Green
(Figure 4D; Movie S2). Finally, we injected mice bearing estab-
lished NCI-NH1650 xenografts with AECase. Mirroring the
in vitro results, tumor growth was significantly retarded in
AECase-treated groups (p = 0.0001; Figure 4E). AECase-
treated mice were also found to upregulate expression of
COX2 (Figure 4F), indicating that they had experienced cystine
depletion and initiated ferroptosis within the tumor (Yang et al.,
2014). Thus, inhibition of tumor growth can be achieved in
tumors sensitive to ferroptosis by enzymatic degradation of
cystine/cysteine in vivo.
DISCUSSION
Cell death by ferroptosis has been implicated in diverse pro-
cesses (Yang and Stockwell, 2016). Previous data indicated
that ferroptosis could be induced preferentially in cells overex-
pressing mutant RAS oncoproteins (Dixon et al., 2012; Dolma
et al., 2003; Yang and Stockwell, 2008) and in some sensitive
cell lines could be blocked by MAPK inhibition (Yagoda et al.,
2007).. Histogram represents the average viability ± SD of cells cultured for 24 hr in
ing cystine (Cys).
e (light bars) or 200 mM BSO (dark bars) in normal media (N), in normal media
cystine for 36 or 12 hr. Histogram represents the average viability ± SD of cells
PX1, GPX2, and ERK in the presence or absence of inhibitors. Relative GPX4/
al replicates, with the ratio in EGFR (delE746-A750) cells assigned a value of 1.
RK1/2. (Right) Histogram of cell viability of HME cells cultured in normal media
average viability ± SD following knockdown GPX1–4. Results were expressed
1.
ollowing transfection with control (siC) or GPX4 small interfering RNAs (siRNAs)
or media lacking cystine for 24 hr. (Right) Histogram is viability ± SD after
lls cultured in normal media (light bars) ormedia lacking cystine (dark bars) were
in normal media assigned the arbitrary value of 1.
GPX4. Dark traces, cells cultured in normal media; light traces, cells cultured in
xpression of Flag-GPX4 (Mannes et al., 2011) in EGFR (delE746-A750) cells.
lls cultured in normal media (light bars) or media lacking cystine (dark bars) for
ility in normal media assigned a value of 1.
in normal media or media deprived of cystine alone or containing catalase or
(delE746-A750) HME cells cultured for 24 hr in normal media (normal; assigned
xide dismutase (SOD), Trolox, or GKT136901 added is shown.
ment with the NOX4 inhibitor GKT136901. Dark traces, cells cultured in media
ages of WT and EGFR (delE746-A750) cells deprived of cystine for 24 hr and
A B
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Figure 4. Ferroptosis Is Induced in Some NSCLC Cell Lines and Inhibits Tumor Growth
(A) Histogram of viability ± SD of EGFR (delE746-A750) HME and NSCLC cell lines cultured for 72 hr in normal media (light bars) or media lacking cystine (dark
bars). Results were expressed for each cell line separately, with viability in normal media assigned a value of 1.
(B) Histogram representing the average viability ± SD of EGFR (delE746-A750) HME (dark bars) or NCI-NH1650 (light bars) cultured for 72 hr in normal media (N),
normal media containing ferrostatin (N/Fer-1), media lacking cystine (Cys), or media lacking cystine in the presence of a-tocopherol or Fer-1. Results were
expressed for each cell line separately, with viability in normal media assigned a value of 1.
(legend continued on next page)
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We identify here a selective cell death of EGFR mutant cells
deprived of the amino acid cystine. Death was associated with
synchronous loss of plasma membrane integrity. By a variety
of criteria, this mode of cell death is ferroptosis. In our model
(Figure 4G), active MAPK signaling downstream of active
EGFR can sensitize cells to ferroptosis upon cystine depletion.
Sensitization involves both impaired detoxification of lipid perox-
ides, due to reduced expression of GPX4, and generation of
hydrogen peroxide, via NOX4. A major consequence of lipid per-
oxidation is loss of impermeability to water (Lis et al., 2011;
Wong-Ekkabut et al., 2007), providing an explanation for the
characteristic cell swelling and rupture we observe.
Sensitivity to induction of ferroptosis or cystine deprivation is
likely to be modulated by additional, and possibly MAPK-inde-
pendent, mechanisms, such as the utilization of the sulfur-con-
taining amino acid methionine via the transsulfuration pathway
(Hayano et al., 2016). Our results suggest, however, the possibil-
ity of exploiting ferroptosis sensitivity in a translational manner.
Tumors with sustained MAPK activation, as found in NSCLC,
are likely to respond to cystine depletion in vivo by inducing
ferroptosis. Our results indicate that an enzymatic approach
(Cramer et al., 2017) may be effective in reducing cystine levels
in vivo, inducing ferroptosis. Collectively, our work indicates
that it might therefore be possible both to identify tumors exhib-
iting increased sensitivity to ferroptosis and to treat them via
cycles of cystine depletion.
EXPERIMENTAL PROCEDURES
Cell Culture and Treatments
The hTERT-HME cell lines were a kind gift from Prof. Alberto Bardelli (Institute
for Cancer Research and Treatment, IRCC). Cells were grown in DMEMmedia
as described (Di Nicolantonio et al., 2008). To deprive individual amino acids,
cells were washed once in DMEM media lacking all amino acids (AA) and
switched to specific amino-acid-free media. DMEM media used for depriva-
tion were made from powdered AA-free DMEM (US Biological), with 10% dia-
lyzed fetal bovine serum (FBS) and additives (Di Nicolantonio et al., 2008).
Amino acids (Sigma) at 503 concentrations in water were added at 13 con-
centration. All amino acids were added for complete media (+AA), with individ-
ual DMEMamino acids omitted to generate single amino-acid-deficientmedia.
For the initial screen, 30,000 cells were plated per well in a 96-well plate and(C) (Left) Histogram of viability ± SD of EGFR (delE746-A750) HME (dark b
(N) (assigned a value of 1), media lacking cystine (Cys), normal media con
(N/AECase/Fer-1), or normal media containing 125 nM heat-inactivated AECa
contrast micrographs of EGFR (delE746-A750) HME cells in normal media,
(N/AECase) for 48 hr are shown.
(D) Phase contrast (left), and Sytox Green (right) micrographs of H1650 cells dep
treated with heat-inactivated AECase (right panels) for various times up to 20 hr.
(E) Cyst(e)inase (AECase) administration inhibits tumor growth in a NCI-NH1650
administration of PBS control (dark circles) or 30 mg/kg (dark squares) or 100 mg
shown. (Right panel) Kaplan-Meier plots of median survival of PBS- or AECase-t
(F) (Top panels) Immunoblots of lysates from control (lanes 1–4) or AECase-treat
head). (Middle histogram) Quantification of relative COX2/ERK in control or AECa
COX2 staining in control and AECase-treated tumors are shown.
(G) Model depicting role of activated EGFR in determining sensitivity to fe
expression of GPX4 and inducing expression of NOX4. GPX4 utilizes reduce
cystine-glutamate exchanger to detoxify membrane lipid peroxides (red), g
reducing equivalents derived from NADPH (dashed line). Cystine can be red
have additional functions (e.g., Briggs et al., 2016). Lipid peroxides are gene
producing hydroxyl radicals that initiate lipid peroxidation. Lipid peroxidation
and rupture.
2554 Cell Reports 18, 2547–2556, March 14, 2017switched after 24 hr to depleted amino acid media for 72 hr. Viability was as-
sessed in the initial screen usingCalcein AM (Molecular Probes; ThermoFisher)
at 1 mM for 2 hr and cells fixed for 15 min with 4% paraformaldehyde prior to
analysis on a Genios plate reader and in all other experiments using the
CellTiter-Glo luminescence assay (Promega).
FACS Analysis
To detect ROS, 200,000 cells were plated in 6-well plates and switched to
cystine-deprived media for 12 hr prior to FACS analysis. CMDCFDA and
C11-BODIPY581/591 (Molecular Probes; Thermo Fisher) were used to detect
total and lipidROS, respectively. Following deprivation of cystine for 12 hr, cells
were washed with PBS, loaded with either CMDCFDA (10 mM) or C11 BODIPY
(2 mM) in DPBS for 30min, trypsinized with 0.25% Trypsin-EDTA, resuspended
inPBSwith 1%FBS, andanalyzedusing anAttuneNxTflowcytometer (Thermo
Fisher). Dyes were excited using a blue 488-nm laser, and emission was re-
corded on BL1 (530/30) for a minimum of 5,000 cells per sample.
Xenograft Tumor Model
2.53 105 NCI-H1650 cells were inoculated 1:1 in Matrigel: PBS (100 mL) by
subcutaneous injection into eight non-obese diabetic (NOD) severe combined
immunodeficiency (SCID) gamma male mice. Tumors were allowed to engraft
and grow for 30 days (tumor volume averaged200mm3) andmice treated by
intraperitoneal (i.p.) injection with 100 mg/kg cyst(e)inase or 100 mg/kg heat-
inactivated cyst(e)inase (n = 4 ea.) on day 30, with a second dose given on
day 33. Mice were necropsied 24 hr after the second dose. For analyses of
COX2, control and treated tumors were excised and one-half preserved in
10%neutral buffered formalin for immunohistochemistry (IHC) and the remain-
ing half frozen in liquid nitrogen for protein extraction. For IHC, anti-COX2 from
Abcam (ab15191) was used with DAB detection.
Statistical Analyses
Data were analyzed using Microsoft Excel or GraphPad Prism software
(GraphPad) and are presented as mean values ± SEM. All viability data repre-
sent the mean of three biological replicates/condition. Statistical analyses
were performed using two-sided Student’s t test. For Kaplan-Meier plots, sta-
tistical significance was analyzed by the log rank (Mantel-Cox) test. Sample
variance was not significant between control and treatment groups prior to
study onset. Significance was set at p < 0.05. All data are representative of
at least two independent experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.02.054.ars) or NCI-NH1650 (light bars) cells cultured for 48 hr in normal media
taining 125 nM cyst(e)inase (AECase) on its own (N/AECase) or with Fer-1
se on its own (N/AECase*) or with Fer-1 (N/AECase*/Fer-1). (Right) Phase-
media deprived of cysteine, or normal media containing 125 nM AECase
rived of cystine (left panels), treated with 125 nM AECase (middle panels), or
xenograft mouse model. (Left panel) Increase in tumor volume following i.p.
/kg (light triangles) AECase is shown. Start and end of treatment times are also
reated tumor-bearing mice are shown.
ed (lanes 5–8) NCI-NH1650 xenograft lysates probed to detect COX2 (arrow-
se-treated groups is shown. p = 0.04; n = 4. (Bottom micrographs) Images of
rroptosis. Activated EGFR (EGFR*) stimulates MAPK signaling, reducing
d glutathione (GSH) derived from cystine transported via the System xc-
enerating oxidized glutathione (GSSG). GSSG is recycled to GSH using
uced to generate cysteine that can independently detoxify ROS and may
rated from hydrogen peroxide (H2O2, derived from NOX4) and iron (Fe
2+),
leads to loss of membrane integrity, allowing uptake of water, cell swelling,
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